Johnny Yu
Co-Founder & CSO, Tahoe Therapeutics · 1 appearance on the record.
computed by AI from the episodes · how this works → · full disclaimer →
founderscientistexecutive@IAmJohnnyYu ↗LinkedIn ↗tahoebio.ai ↗
Johnny Yu co-founded Tahoe Therapeutics to generate in vivo single-cell perturbation datasets for training AI models of human cellular responses. Holding a Ph.D. from UCSF, he developed the company's Mosaic platform and spearheaded the Tahoe-100M atlas in partnership with the Arc Institute.
1 supported 1 partly supported 0 contradicted 2 not checkable as stated how the 4 claims stand · each chip opens the sources
1 prediction · 3 assertions · 1 disclosure · every statement was checked. The prediction and assertions are the 4 claims: statements the public record can support or contradict. 2 are resolved, and 2 name no date, number or outcome precise enough to check. Everything else (opinions, insights, what ifs, disclosures) can never be settled by the record, so it carries no assessment.
The record, in short
What the tape says about how Johnny argues and how the claims held up. Everything they said, and everything said about them, is in the tabs below.
Their most notable supported claim
How they sound: not measured why? →
We measure speaking style by listening to the audio itself, and a fair number needs at least 2,000 words from one person on tape we have measured. There is too little of Johnny Yu on measured tape to publish a rate. This says nothing about how they speak.
Everything Johnny Yu said on No Priors that made the record, most notable first. Filter by type, assessment or year in the ledger →
Appearances (1)
| Episode | Date | Speaking time |
|---|---|---|
| No Priors Ep. 103 | With Vevo Therapeutics and the Arc Institute | Feb 25, 2025 | 4m |